Advertisement
Screener

NUTRA PHARMA CORP. (NPHC) Line of Credit Facility, Increase, Accrued Interest

NUTRA PHARMA CORP. Line of Credit Facility, Increase, Accrued Interest

NUTRA PHARMA CORP. (NPHC) reported Line of Credit Facility, Increase, Accrued Interest of $32.68 thousand for the 6-month period ending 2020-06-30, per its 10-Q filed 2021-08-05.

Discontinued › Notes › Debt › Line of Credit Facility

us-gaap:LineOfCreditFacilityIncreaseAccruedInterest · last filed 2021-08-05

  • NUTRA PHARMA CORP. line of credit facility, increase, accrued interest for the quarter ending 2020-06-30 was $0.00.
  • NUTRA PHARMA CORP. line of credit facility, increase, accrued interest for the quarter ending 2020-03-31 was $32.68K.
  • NUTRA PHARMA CORP. line of credit facility, increase, accrued interest for the quarter ending 2019-12-31 was $2.76K.
  • NUTRA PHARMA CORP. line of credit facility, increase, accrued interest for the quarter ending 2018-09-30 was $4.00K.
  • NUTRA PHARMA CORP. line of credit facility, increase, accrued interest for fiscal 2019 was $29.95K.
Period endLine of Credit Facility, Increase, Accrued Interest 1 monthLine of Credit Facility, Increase, Accrued Interest 3 monthLine of Credit Facility, Increase, Accrued Interest 6 monthLine of Credit Facility, Increase, Accrued Interest 9 monthLine of Credit Facility, Increase, Accrued Interest 12 month
2020-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05
$32.68K
10-Q · filed 2021-08-05
$35.43K
derived: sum of 3 quarters · filed 2021-08-05
2020-03-31$32.68K
10-Q · filed 2021-07-23
$35.43K
derived: sum of 2 quarters · filed 2021-07-23
2019-12-31$2.76K
derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-01
$29.95K
10-K · filed 2021-07-01
2019-09-30$27.19K
10-Q · filed 2021-05-14
2019-02-28$11.41K
10-Q · filed 2021-04-05
2018-09-30$4.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-19
$7.88K
derived: sum of 2 quarters · filed 2018-11-19
$137.65K
10-Q · filed 2018-11-19
2018-06-30$3.88K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-17
$133.65K
10-Q · filed 2018-08-17
2018-03-31$129.76K
10-Q · filed 2018-05-21